Dfpg Investments, LLC Castle Biosciences Inc Transaction History
Dfpg Investments, LLC
- $1.29 Billion
- Q4 2023
A detailed history of Dfpg Investments, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dfpg Investments, LLC holds 13,649 shares of CSTL stock, worth $390,497. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,649
Previous 14,415
5.31%
Holding current value
$390,497
Previous $243,000
20.99%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$87.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$52.2 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$50 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$36.1 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$35.9 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $752M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...